Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
Abstract
Synaptic vesicle glycoprotein (SV)2A is a transmembrane protein found in secretory vesicles and is critical for Ca 2+‐dependent exocytosis in central neurons, although its mechanism of action remains uncertain. Previous studies have proposed, variously, a role of SV 2 in the maintenance and formation of the readily releasable pool (RRP) or in the regulation of Ca 2+ responsiveness of primed vesicles. Such previous studies have typically used genetic approaches to ablate SV 2 levels; here, we used a strategy involving small interference RNA (si RNA) injection to knockdown solely presynaptic SV 2A levels in rat superior cervical ganglion (SCG) neuron synapses. Moreover, we investigated the effects of SV 2A knockdown on voltage‐dependent Ca 2+ channel (VDCC) function in SCG neurons. Thus, we extended the studies of SV 2A mechanisms by investigating the effects on vesicular transmitter release and VDCC function in peripheral sympathetic neurons. We first demonstrated an si RNA‐mediated SV 2A knockdown. We showed that this SV 2A knockdown markedly affected presynaptic function, causing an attenuated RRP size, increased paired‐pulse depression and delayed RRP recovery after stimulus‐dependent depletion. We further demonstrated that the SV 2A–si RNA‐mediated effects on vesicular release were accompanied by a reduction in VDCC current density in isolated SCG neurons. Together, our data showed that SV 2A is required for correct transmitter release at sympathetic neurons. Mechanistically, we demonstrated that presynaptic SV 2A: (i) acted to direct normal synaptic transmission by maintaining RRP size, (ii) had a facilitatory role in recovery from synaptic depression, and that (iii) SV 2A deficits were associated with aberrant Ca 2+ current density, which may contribute to the secretory phenotype in sympathetic peripheral neurons.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SV2A stabilizes vesicle content and maintains the readily releasable pool, tuning short-term plasticity and sustaining output during repeated activity.
“SV2A also stabilizes vesicle content and maintains the readily releasable pool, thereby tuning short term plasticity and sustaining output during repeated activity [185,186,194].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [194]
Cites
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415 · cited 3× · see citing works
“and, as a consequence, a severely restricted lifespan (Crowder et al., 1999; Janz et al., 1999).”
BackgroundResultShort-term forms of presynaptic plasticity
Fioravante, D., & Regehr, W. G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.02.003 · Cited by 375 · see citing works
SV2, a Brain Synaptic Vesicle Protein Homologous to Bacterial Transporters
Bajjalieh, S. M., Peterson, K., Shinghal, R., & Scheller, R. H. (1992) · Science · doi:10.1126/science.1519064 · Cited by 256 · see citing works
SV2 modulates the size of the readily releasable pool of secretory vesicles
Xu, T., & Bajjalieh, S. M. (2001) · Nature Cell Biology · doi:10.1038/35087000 · Cited by 212 · see citing works
Synaptic vesicle protein 2 enhances release probability at quiescent synapses
Custer, K. L., Austin, N. S., Sullivan, J. M., & Bajjalieh, S. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2699-05.2006 · Cited by 211 · see citing works
SV2 Renders Primed Synaptic Vesicles Competent for Ca<sup>2+</sup>-Induced Exocytosis
Chang, W.-P., & Südhof, T. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4521-08.2009 · Cited by 176 · see citing works
Gillard, M., Chatelain, P., & Fuks, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.022 · Cited by 148 · see citing works
Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
Nowack, A., Malarkey, E. B., Yao, J., Bleckert, A., Hill, J., & Bajjalieh, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029560 · Cited by 81 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296 · see citing works
Levetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131 · see citing works
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123 · see citing works
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00351 · Cited by 112 · see citing works
Wu, P.-P., Cao, B.-R., Tian, F.-Y., & Gao, Z.-B. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01138-2 · Cited by 35 · see citing works
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
- Authors
- Vogl, C., Tanifuji, S., Danis, B., Daniels, V., Foerch, P., Wolff, C., Whalley, B. J., Mochida, S., & Stephens, G. J.
- Affiliations
- University of Reading (GB)
- Tokyo Medical University (JP)
- UCB Centre for CNS Innovation UCB Pharma SA Braine l'Alleud Belgium
- UCB Pharma (Belgium) (BE)
- Corresponding author
- Stephens, Gary J.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2014-12-08
- Volume
- 41
- Issue
- 4
- Pages
- 398-409
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2111853543
- Cited by
- 35
- References
- 8
- Citations by year
- 2026: 1 · 2025: 4 · 2023: 1 · 2022: 8 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 4 · 2016: 2 · 2015: 2
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for Promotion of Science
- UCB Pharma Postdoctoral Fellowship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- SV2A, vesicle exocytosis, readily releasable pool, voltage-gated calcium channels, presynaptic function, superior cervical ganglion, sympathetic neurons, paired-pulse depression, calcium current density, siRNA knockdown, secretory phenotype
- MeSH terms
- Animals, Cells, Cultured, Exocytosis, Humans, Male, Membrane Glycoproteins, Synaptic Transmission, Synapses, Synaptic Vesicles, Calcium Channels, Rats, Wistar, Superior Cervical Ganglion, Rats, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review